series-a
Stage
1
Investors
About
Dendrogenix is a Belgian biopharmaceutical company developing novel small molecule drugs called Dendrogenins that promote cell differentiation and support neuron and dendritic cell growth to treat hearing loss and neurological diseases.
Explore DENDROGENIX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.